CNS 2024 Conference Presentation: Diakonos Oncology’s Autologous Dendritic Cell Vaccine (DOC1021) Yields 93% 12-Month Survival for Glioblastoma Patients.

Abstract 839: Single-cell, pooled CRISPR screening reveals T cell intrinsic regulators of exhaustion in context of chronic antigen stimulation Date and Time: May 8, 2024 at 12:00 p.m. Presenter ...

The image appeared during a presentation by Mike McCauliffe, head of Luminar’s semiconductor team. The full Luminar Day webcast on YouTube, which had nearly 750,000 views, was taken down and ...

Data from the Phase 1 clinical trial of novel KCNK13 inhibitor showed good CNS exposure and was generally well-tolerated <li /> Proprie ...

HOPEWELL, N.J., April 23, 2025 /PRNewswire/ -- ProBio, a global contract development and manufacturing organization (CDMO), announced that it will present six poster presentations at the American ...

TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 28th Annual Meeting Provided by GlobeNewswire Apr 28, 2025, 8:53:52 PM ...

Northwest Biotherapeutics Announces Upcoming Presentation On Next Generation Dendritic Cells for Enhanced Anti-Tumor Treatments PR Newswire Wed, Jun 11, 2025, 12:49 PM 2 min read ...

In 36 patients with CD30-positive lymphoma treated at the recommended Phase 2 dose level (RP2D), the combination treatment of AFM13 with allogeneic NK cells shows a 94.4% objective response rate ...

TScan Therapeutics announced an accepted abstract for poster presentation at ASGCT's annual meeting on TCR-engineered therapies for cancer. TScan Therapeutics, Inc., a clinical-stage biotechnology ...

The Adocia presentation at the American Diabetes Association’s (ADA) 85 th Scientific Sessions, held in Chicago, USA, June 20-23, 2025, titled "AdoShell ®, a non-fibrotic encapsulation system ...